ES2182330T3 - Procedimiento para la preparacion selectiva de isomeros z de 3-(2-vinil-sustituido) cefalosporina. - Google Patents

Procedimiento para la preparacion selectiva de isomeros z de 3-(2-vinil-sustituido) cefalosporina.

Info

Publication number
ES2182330T3
ES2182330T3 ES98929666T ES98929666T ES2182330T3 ES 2182330 T3 ES2182330 T3 ES 2182330T3 ES 98929666 T ES98929666 T ES 98929666T ES 98929666 T ES98929666 T ES 98929666T ES 2182330 T3 ES2182330 T3 ES 2182330T3
Authority
ES
Spain
Prior art keywords
group
hydrogen atom
indicates
amino protecting
vinyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98929666T
Other languages
English (en)
Inventor
Yumiko Okada
Masamichi Sukegawa
Tatsuo Watanabe
Hiroyuki Iwasawa
Yasushi Murai
Katsuharu Iinuma
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meiji Seika Kaisha Ltd
Original Assignee
Meiji Seika Kaisha Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Kaisha Ltd filed Critical Meiji Seika Kaisha Ltd
Application granted granted Critical
Publication of ES2182330T3 publication Critical patent/ES2182330T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02—Preparation
    • C07D501/04—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Un procedimiento para la producción selectiva del isómero Z de un ácido 7-N-amino(sustituido o no sustituido)-3-[2-(4-tiazol(sustituido o no sustituido)-5-il)]vinil-3-cefemo-4-carboxílico o un éster suyo representado por la siguiente fórmula general (IV) **(Ver fórmula)** en la que R1 indica un átomo de hidrógeno o un grupo protector monovalente del amino, o R1 indica un grupo 2-(2-N-aminotiazol(protegido o no protegido)-4-il)-2-alcoxiiminoacetilo que tiene la siguiente fórmula (II) **(Ver fórmula)** donde R5 es un átomo de hidrógeno o un grupo monovalente protector del amino y R6 es un átomo de hidrógeno, o R5 y R6, tomados conjuntamente, significan un grupo divalente protector del amino, y R7 es un grupo alquilo de 1-4 átomos de carbono y en la que R2 indica un átomo de hidrógeno, o R1 y R2, tomados conjuntamente, significan un grupo divalente protector del amino y R3 indica un átomo de hidrógeno, un grupo pivaloiloximetilo o un grupo formador de éster, como un grupo protector del carboxilo, y R8 indica un átomo de hidrógeno, un grupo alquilo de 1-4 átomos de carbono, un grupo trifluorometilo o un grupo cloro.
ES98929666T 1997-06-24 1998-06-24 Procedimiento para la preparacion selectiva de isomeros z de 3-(2-vinil-sustituido) cefalosporina. Expired - Lifetime ES2182330T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP16694897 1997-06-24

Publications (1)

Publication Number Publication Date
ES2182330T3 true ES2182330T3 (es) 2003-03-01

Family

ID=15840609

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98929666T Expired - Lifetime ES2182330T3 (es) 1997-06-24 1998-06-24 Procedimiento para la preparacion selectiva de isomeros z de 3-(2-vinil-sustituido) cefalosporina.

Country Status (24)

Country Link
US (1) US6288223B1 (es)
EP (1) EP1016665B1 (es)
JP (1) JP3713282B2 (es)
KR (1) KR100515273B1 (es)
CN (1) CN1107679C (es)
AT (1) ATE221890T1 (es)
AU (1) AU731265B2 (es)
BR (1) BR9810313B1 (es)
CA (1) CA2294178C (es)
CZ (1) CZ295599B6 (es)
DE (1) DE69807093T2 (es)
EA (1) EA002449B1 (es)
ES (1) ES2182330T3 (es)
HU (1) HU228767B1 (es)
ID (1) ID24210A (es)
IL (1) IL133681A (es)
NZ (1) NZ502234A (es)
PL (1) PL193367B1 (es)
PT (1) PT1016665E (es)
RO (1) RO120261B1 (es)
SK (1) SK283525B6 (es)
TR (1) TR200000310T2 (es)
UA (1) UA55463C2 (es)
WO (1) WO1998058932A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4157177B2 (ja) * 1997-06-04 2008-09-24 大塚化学ホールディングス株式会社 ３−アルケニルセフェム化合物の製造法
WO2005003141A2 (en) * 2003-07-04 2005-01-13 Orchid Chemicals & Pharmaceuticals Ltd An improved process for the preparation of cefditoren
EP1660505A2 (en) * 2003-08-14 2006-05-31 Ranbaxy Laboratories Limited Process for selective preparation of z-isomer of cefditoren and pharmaceutically acceptable salts and esters thereof
WO2005100369A1 (en) * 2004-04-13 2005-10-27 Ranbaxy Laboratories Limited Depletion of e-isomers in preparation of z-enriched 3-(2-substituted vinyl) cephalosporins
WO2005100367A1 (en) * 2004-04-13 2005-10-27 Ranbaxy Laboratories Limited Intermediates useful in the synthesis of 3-(2-substituted vinyl) cephalosporins
JP4064948B2 (ja) * 2004-06-04 2008-03-19 明治製菓株式会社 ３−アルケニルセフェム化合物及び製造方法
JP4046708B2 (ja) * 2004-06-04 2008-02-13 明治製菓株式会社 ３−アルケニルセフェム化合物の製造方法
TW200619222A (en) * 2004-09-02 2006-06-16 Rohm & Haas Elect Mat Method for making organometallic compounds
JP2006096679A (ja) * 2004-09-28 2006-04-13 Meiji Seika Kaisha Ltd セファロスポリン化合物の製造方法
CN101665499A (zh) * 2008-09-01 2010-03-10 日本化学工业株式会社 头孢烯化合物的制造方法
EP2520578A1 (en) 2011-05-06 2012-11-07 Lupin Limited Process for purification of cephalosporins
CN105622636B (zh) * 2016-02-05 2017-08-25 河南理工大学 一种头孢妥仑匹酯中间体的制备方法
CN113480491B (zh) * 2021-09-08 2022-05-06 山东昌邑四方医药化工有限公司 一种从头孢托仑母核生产废液中回收4-甲基噻唑-5-甲醛和三苯基氧膦的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6219593A (ja) 1985-07-18 1987-01-28 Meiji Seika Kaisha Ltd 新規セフエム化合物
IE58487B1 (en) * 1984-09-07 1993-09-22 Kaisha Maiji Seika New cephalosporin compounds and the production thereof
JPH03128382A (ja) 1989-07-18 1991-05-31 Eisai Co Ltd チアゾリルアセトアミドセフェム系化合物
JPH06219593A (ja) * 1993-01-21 1994-08-09 Oki Electric Ind Co Ltd 電子写真記録装置
JP3128382B2 (ja) 1993-03-11 2001-01-29 旭 中野 鉄道車両運行支援表示装置
ATE198892T1 (de) * 1993-11-17 2001-02-15 Biochemie Gmbh Trennung von cephalosporinisomeren
JPH0867684A (ja) 1994-08-31 1996-03-12 Kyorin Pharmaceut Co Ltd 新規セフェム化合物、その製造法及び抗菌剤

Also Published As

Publication number Publication date
ATE221890T1 (de) 2002-08-15
SK283525B6 (sk) 2003-09-11
EA200000065A1 (ru) 2000-08-28
EA002449B1 (ru) 2002-04-25
AU731265B2 (en) 2001-03-29
CA2294178A1 (en) 1998-12-30
BR9810313A (pt) 2000-09-19
IL133681A0 (en) 2001-04-30
JP3713282B2 (ja) 2005-11-09
NZ502234A (en) 2001-06-29
SK185799A3 (en) 2000-07-11
PL193367B1 (pl) 2007-02-28
KR20010014074A (ko) 2001-02-26
RO120261B1 (ro) 2005-11-30
US6288223B1 (en) 2001-09-11
HU228767B1 (en) 2013-05-28
KR100515273B1 (ko) 2005-09-15
WO1998058932A1 (fr) 1998-12-30
AU7933198A (en) 1999-01-04
CN1107679C (zh) 2003-05-07
ID24210A (id) 2000-07-13
CZ295599B6 (cs) 2005-08-17
UA55463C2 (uk) 2003-04-15
BR9810313B1 (pt) 2010-11-30
PL339361A1 (en) 2000-12-18
HUP0002458A2 (hu) 2001-02-28
IL133681A (en) 2003-10-31
CZ471899A3 (cs) 2000-07-12
TR200000310T2 (tr) 2000-08-21
DE69807093T2 (de) 2003-03-27
DE69807093D1 (de) 2002-09-12
EP1016665A1 (en) 2000-07-05
HUP0002458A3 (en) 2001-04-28
PT1016665E (pt) 2002-12-31
CN1265662A (zh) 2000-09-06
EP1016665B1 (en) 2002-08-07
CA2294178C (en) 2003-07-22
EP1016665A4 (en) 2001-06-13

Similar Documents

Publication Publication Date Title
ES2182330T3 (es) Procedimiento para la preparacion selectiva de isomeros z de 3-(2-vinil-sustituido) cefalosporina.
YU20194A (sh) 1H-INDOL-3-ACETAMIDI KAO INHIBITORI s PLA2
TW430664B (en) Substituted carboxamidothiazoles, their preparation and pharmaceutical compositions containing them
ES2141174T3 (es) 4-arilmetiloximetil piperidinas como antagonistas de taquiquinina.
ATE13422T1 (de) Derivate von 1-aryl-2-aminomethyl-cyclopropancarboxamiden (z), ihre herstellung und ihre verwendung fuer die behandlung von stoerungen des zentralnervensystems.
GT200100137A (es) Pro-drogas de derivados de 4-fenil-piridina.
BR9510006A (pt) Derivados de anilina possuindo efeito inibidor de sintase do óxido nítrico
ATE339409T1 (de) Trizyklische verbindungen
DE69823648D1 (de) 1-phenyl-4-benzylpiperazine: spezifische liganden für den dopamin rezeptor (d4)
DE60332562D1 (de) Therapeutische Piperazinverbindungen
YU101302A (sh) Derivat benzoilpiridina ili njegova so, fungicid koji ga sadrži u vidu aktivnog sastojka, postupak za njegovu proizvodnju i intermedijer za njegovo dobijanje
BR9401407A (pt) Sais de metais alcalino-terrosos, sais de metais de transição e complexos de metais de transição, composição de revestimento, emprego de compostos, processos para proteger um substrato de metal e para a preparação de sais de metais e produto
DOP2000000106A (es) 2-(3,5-bis-trifluorometil-fenil)-n-metil-n-(6-morfolin-4-il-4-o-tolil-piridin-3-il)-isobutiramida
MX9405290A (es) Derivados de piperazina y sales de los mismos, proceso para su preparaciony medicamentos que los contienen.
DE68914225D1 (de) 3-Oxiranbenzoesäuren und Derivate.
AR003137A1 (es) Una composicion farmaceutica para tratar la leucemia
ES2181793T3 (es) Diazepino-indoles como inhibidores de fosfodiesterasas iv.
BR9911250A (pt) Processo para preparação de compostos
ES2157989T3 (es) Nuevos derivados de cefalosporina.
ES2124411T3 (es) 1-arilcicloalquil-sulfuros, -sulfoxidos y -sulfonas para el tratamiento de depresion, ansiedad y enfermedad de parkinson.
MX9600816A (es) Nuevos derivados triciclicos, su preparacion, su aplicacion a la preparacion de la colquicina y de la tiocolquicina, opticamente activas o racemicas, y de compuestos analogos o derivados e intermedios.
PT83334B (pt) Processo para a preparacao de compostos beta-lactamicos
ES2171299T3 (es) Procedimiento quimico para la reduccion de 3-hidroximetil-4-(4-fluorofenil)tetrahidropiridinas substituidas en 1.
DK1347965T3 (da) Hidtil ukendte desloratidinsalte, fremgangsmåde til syntese deraf samt farmaceutiske præparater deraf
AR004015A1 (es) Procedimiento para preparar compuestos de quinolina o sales farmaceuticamente aceptables de los mismos, y compuestos intermediarios